Endorsements

Don't take our word for it...

“Mark was instrumental in identifying an extensive list of potential investors and strategic partners to finance a Phase 3 programme for the company’s lead asset. He effectively leveraged his extensive industry network as well as seeking out new contacts. He brokered and skilfully led dozens of introductory calls and meetings and in so doing cultivated a number of business relationships that persist still. I enjoyed working with Mark and the business benefitted from his industry, persistence and knowledge. Not only did he lead the line for the business development function, Mark could also be relied upon to provide informed and creative strategic thinking. At the end of 2021, the company secured a strategic partnership and the Phase 3 programme will begin early in 2023.”

Ian Vessey, Founder & Managing Director

“Mark built a funding target list of over 350 potential investors. He managed the process of setting up meetings, briefing the team and following up with the top opportunities. His sound strategic advice, persistence and hard work were evident throughout. In the end he successfully guided us to finding an outstanding investment partner. Our path to successful commercialization is now well underway.”

Kipton P. Lade BSc, MSc, MBA, Chief Executive Officer

“Our sincere gratitude to you Mark for your focus, skills that incorporate nuance, and the ability to speak plainly to complete stages of interaction with prospective buying interests to move forward in a positive manner. His demeanour, positive reinforcement, professional comportment, and most-importantly competence was greatly appreciated. We could not have obtained this result without his guidance.”

Don & Rose Titus, Owners

“Mark acted as the Integration Lead for Alcon in the incorporation of the Alcon Pharmaceutical Business Unit into Novartis Pharmaceuticals. In particular, Mark focused on, business model optimization, stakeholder communications, and integration of the commercial, regulatory, operations, medical, quality assurance, and legal functions. Mark provided highly valued business area expertise and strategic guidance throughout the process, helping us achieve a seamless integration. In addition to his extensive life science industry knowledge and experience, he is a tremendous collaborator who immediately gains respect from all team members due to his diplomacy, engaging leadership, and personal energy. Mark is an absolute pleasure to work with.”

Kyle Steiger, Former Vice President, Ophthalmology Business Unit

“Mark is a wonderful mentor, a great strategist and a highly ethical leader. We are grateful to Mark for his instrumental role in building a strong foundation for our start-up and in planning and executing a highly effective commercialization campaign. “

Shiva Darvishi, M.Sc., Co-Founder & Chief Operating Officer

“Mark did an outstanding job guiding our strategic planning session this year keeping us on track to a highly successful outcome. His creativity and leadership were of great use and very much appreciated. We have since engaged Life Sciences Consulting to help us in our Business Development efforts and to secure additional investment for our forthcoming expansion.”

Don Stewart, Founder & CEO

“Mark has worked with Mercana on a number of deals over the last three years. He is reliable, hard working and very effective at every stage of the financing process. He has built an impressive network of potential investors and develops target lists that are focussed on the development stage of our clients. He is equally as effective building strong relationships and trust with clients, working with them to refine their strategy, build pitch decks, prepare them for presentations, guide them through the due diligence process and close deals. He is an absolute pleasure to work with.”

Bill Thompson, Managing Partner

“JLSC has been a tremendous partner for Cameron Thomson. Their investor network is extensive and their ability to uncover other Venture Capital and Angel investors specific to each opportunity is impressive. It is a pleasure working with the team. They build relationships quickly, are persistent in their outreach and bring the right investors to the table.”

Ron Thomson, Founder & President

“We were in need of a market assessment on very tight timelines for a potential BD&L deal. LSC delivered on time and below budget with an insightful and strategic overview on the therapeutic area we were investigating. This included clear answers on core questions on competition, strategy, timing and potential for success, helping us make the right decision.”

Jason Locklin, Head, Market Access & Government Relations